Welcome to the e-CCO Library Archive!
Interspace microbiome profiling (IS-pro) enables to differentiate IBD subclasses and disease activity by specific loss of bacterial diversity
M. Grasman1, R. van der Borden1, A. Budding2, A. Eck Hauer2, P. Savelkoul2, A. van Bodegraven3, 1VU University Medical Centre, Gastroenterology and Hepatology, Amsterdam, Netherlands, 2VU University Medical Centre, Medical Microbiology and Infection control, Amsterdam, Netherlands, 3ORBIS Medical Centre, Gastroenterology and Hepatology, Sittard, Netherlands
M. Wildenberg1, A. Levin2, C. Vos2, J. Brandse1, J. de Bruyn1, G. D'Haens1, G. van den Brink1, 1Academic Medical Center, Gastroenterology, Amsterdam, Netherlands, 2Academic Medical Center, Tytgat Institute for Intestinal and Liver Research, Netherlands
Fertility in IBD women is comparable to fertility in non-IBD controls
A. de Lima*1, M. van Amelsfort1, E. Steegers2, C.J. van der Woude1
1Erasmus Medical Center, Gastroenterology and Hepatology, Rotterdam, Netherlands, 2Erasmus Medical Center, Obstetrics and Gynecology, Rotterdam, Netherlands
Inflammatory bowel disease and Epstein–Barr virus: analysis of our experience
Á. Araujo Míguez, C. Trigo Salado, J.L. Márquez Galán, M.D. De la Cruz Ramírez, J.M. Herrera Justiniano, E. Leo Carnerero, Hospital Universitario Virgen del Rocío, Gastroenterology, Seville, Spain
U. Grzybowska-Chlebowczyk1, A.L. Sieron2, H. Koryciak-Komarska2, S. Wiecek3, M. Kniazewska3, L. Sieron2, H. Wos3, 1Medical University of Silesia, Department of Paediatrics, Katowice, Poland, 2Medical University of Silesia, Department of General and Molecular Biology and Genetics, Poland, 3Medical University of Silesia, Department of Pediatrics, Katowice, Poland
Inflammatory Bowel Disease is prevalent in Australia but rare in Indigenous Australians
G. Iyngkaran*1, J. Hunt2, T. Thambimuthu2, M. Bottolfsen2, E. Tse3, S. Sivanesan1, D. Liew4
1Royal Melbourne Hospital, Colorectal Medicine and Genetics, Parkville, Australia, 2Royal Darwin Hospital, Medicine, Darwin, Australia, 3Royal Adelaide Hospital, Medicine, Adelaide, Australia, 4Royal Melbourne Hospital, Medicine, Parkville, Australia
Efficacy of vaccination against hepatitis A and B in inflammatory bowel disease patients
K. Karmiris1, E. Voudoukis1, M. Choustoulaki2, A. Sfiridaki2, G.A. Paspatis1, 1Venizeleio General Hospital, Gastroenterology, Heraklion, Crete, Greece, 2Venizeleio General Hospital, Blood Bank Center, Heraklion, Crete, Greece
M. Chaparro1, A. González-Neira2, M. Román3, G. Pita2, T. Cabaleiro4, D. Herrero2, B. Herraez2, R. Alonso2, C. Taxonera5, P. López-Serrano6, P. Martínez Montiel7, I. Vera8, F. Bermejo9, A. López-San Román10, F. Abad-Santos4, J.P. Gisbert1, 1Hospital Universitario de la Princesa-IP, Gastroenterology and CIBEREHD, Madrid, Spain, 2Spanish National Cancer Research Centre, Madrid, Spain, 3Hospital Universitario de la Princesa-IP, Clinical Pharmacology and CIBEREHD, Madrid, Spain, 4Hospital Universitario de La Princesa, Clinical Pharmacology Service, Madrid, Spain, 5Hospital Universitario Clínico San Carlos, Gastroenterology, Madrid, Spain, 6Hospital de Alcorcón, Gastroenterology, Madrid, Spain, 7Hospital Universitario Doce de Octubre, Gastroenterology, Madrid, Spain, 8Hospital Universitario Puerta de Hierro, Gastroenterology, Madrid, Spain, 9Hospital Universitario de Fuenlabrada, Gastroenterology, Madrid, Spain, 10Hospital Universitario Ramón y Cajal, Gastroenterology, Madrid, Spain
Perception about disease activity and treatment attributes in patients with Ulcerative Colitis from Spain - UC-life survey
A. López-Sanromán*1, D. Carpio2, X. Calvet3, L. Cea-Calvo4, C. Romero4, F. Argüelles5
1Hospital Ramón y Cajal, Gastroenterology Unit, Madrid, Spain, 2Complexo Hospitalario Universitario , Gastroenterology, Pontevedra, Spain, 3Corporació Sanitària Universitària Parc Taulí, Digestive Disease Department. Departament de Medicina. Universitat Autònoma de Barcelona. CIBEREHD – Instituto de Salud Carlos III, Sabadell, Spain, 4Merck Sharp & Dohme, Medical Affairs, Madrid, Spain, 5Hospital Universitario Virgen Macarena, Gastroenterology Unit, Sevilla, Spain
Effects of isotretinoin treatment on murine gut microbiota composition
E. Becker1, C. Stanzel1, S. Schmidt2, K. Atrott1, L. Biedermann1, A. Rehman3, D. Jonas3, C. von Mering2, G. Rogler1, I. Frey-Wagner1, 1University Hospital Zurich, Gastroenterology & Hepatology, Zurich, Switzerland, 2University of Zurich, Molecular Life Sciences, Zurich, Switzerland, 3University Medical Center, Environmental Health Sciences, Freiburg, Germany
T.B. Murdoch1, A. Ueno1, G. Kaplan1, R. Panaccione1, H. Jijon1, M. Silverberg2, C. Hirota1, S. Ghosh1, 1University of Calgary, Division of Gastroenterology, Calgary, Canada, 2University of Toronto, Toronto, Canada
The 5 year incidence of post-operative clinical recurrence following ileocolonic resection for terminal ileal Crohn's disease
P. Morar*, O. Faiz, A. Hart, J. Warusavitarne
St Mark's Hospital, Colorectal Surgery & IBD Unit, London, United Kingdom
Does the ileocecal valve functionally separate ileal and right-sided colon microbiota compositions?
N. Rossen1, S. Fuentes2, G. D'Haens1, H. Heilig2, K. Boonstra1, E. Zoetendal2, W. de Vos2, C. Ponsioen1, 1Academic Medical Center, Gastroenterology & Hepatology, Amsterdam, Netherlands, 2Wageningen University, Laboratory of Microbiology, Wageningen, Netherlands
C. Strisciuglio1, E. Miele1, M.E. Wildenberg2, F.P. Giugliano1, M. Andreozzi1, A. Vitale1, F. Capasso1, M.V. Barone1, A. Staiano1, R. Troncone1, C. Gianfrani1, 1Federico II, Pediatrics, Naples, Italy, 2Intestinal and Liver Research, Academic Medical Center, Gastroenterology and Hepatology and Tytgat, Amsterdam, Netherlands
The impact of ethnicity on the prevalence and length of hospital stay in patients with Crohn's Disease
J. Khan*1, S. Shan1, F. Ziaei1, R. Bhayani1, S. Shakir1, H. Uppal2, S. Chandran3, R. Potluri2
1Pennine Acute Hospitals NHS Trust, Medicine, Manchester, United Kingdom, 2Aston University, ACALM Study Unit in collaboration with Aston Medical School, Birmingham, United Kingdom, 3North Western Deanery, Department of Acute Medicine, Manchester, United Kingdom
Determination of the discriminant score of intestinal microbiota as a biomarker of disease activity in patients with ulcerative colitis
K. Fukuda, Y. Fujita, St Luke's International Hospital, Department of Gastroenterology, Tokyo, Japan
C. Strisciuglio1, M. Martinelli1, F.P. Giugliano1, M. Andreozzi1, C. Greco1, C. Gianfrani1, A. Staiano1, R. Troncone1, E. Miele1, 1Federico II, Pediatrics, Naples, Italy
Annual Incidence of IBD in Otago, New Zealand: An 18-year Epidemiological Analysis
C. Galts1, F. Huinzing1, A. Gray2, J. Norton1, K. Copell1, M. Schultz*1
1University of Otago, Department of Medicine, Dunedin School of Medicine, Dunedin, New Zealand, 2University of Otago, Department of Preventive and Social Medicine, Dunedin School of Medicine, Dunedin, New Zealand
DNA of Helicobacter species is present in patients with inflammatory bowel diseases
M. Biernat1, R. Kempinski2, K. Neubauer2, A. Binkowska1, J. Grabinska1, G. Gosciniak1, E. Poniewierka2, 1Wroclaw Medical University, Microbiology, Wroclaw, Poland, 2Wroclaw Medical University, Gastroenterology and Hepatology, Wroclaw, Poland
S. Cardile1, I. Loddo2, R. Mallamace1, F. Sancetta1, T. Alterio1, R. Centorrino1, C. Romano1, 1AOU G. Martino, Pediatric Department, Messina, Italy, 2AOU G. Martino, Genetic and Pediatric Immunology, Messina, Italy